Analysts

Wall Street · Earnings · Institutional Sentiment

A comprehensive analysis section that covers unveiling insights about Crinetics Pharmaceuticals, Inc.'s gradings, price targets and earnings estimates.

Earnings

See the historical earnings and what wall street analysts forecasted and
forecast for future earnings.

Reported

Past Estimate Consensus

Future Estimate Consensus

EPS Revenue EBITDA EBIT SGA

All monetary values are presented in USD ($). E stands for Estimate.
FY	EPS		Revenue [mil.]		Profit [mil.]		EBITDA [mil.]		EBIT [mil.]		Expenses · SGA [mil.]
		E		E		E		E		E		E
2018	-	-2.838	-	1	-	-164	-	-1	-	-1	-	115
2019	-2.2300	-2.163	2	1	-27	-125	-28	-1	-26	-1	6	62
2020	-2.0500	-2.352	1	0.09	-49	-136	-53	0.09	-53	0.09	13	5
2022	-2.7800	-3.164	1	4	-106	-183	-107	-4	-108	-4	24	265
2023	-3.0800	-3.632	4	4	-159	-212	-167	-4	-169	-4	42	263
2024	-	-3.695	-	1	-	-214	-	-1	-	-1	-	124
2025	-	-3.858	-	11	-	-209	-	-11	-	-11	-	737
2026	-	-3.789	-	51	-	2.F7X	-	2.F71	-	2.F711	-	2.F711
2027	-	-2.253	-	172	-	1.F8X	-	1.F81	-	1.F811	-	1.F811
2028	-	0.090	-	437	-	0.F9X	-	0.F91	-	0.F911	-	0.F911

Institutional Sentiment

Wall Street · Earnings · Institutional Sentiment

The institutional sentiment measures the direction of new stock gradings
and price targets while comparing them Year-over-Year. We've limited the grading institutes to those we see as top-tier and update this data every month.

Morgan Stanley

1Y Ago:

n/a

Prev. Grade

n/a

JP Morgan Chase

1Y Ago:

n/a

Prev. Grade

n/a

Citigroup

1Y Ago:

n/a

Prev. Grade

n/a

Overall Consensus

Here we aggregate the price targets and gradings of all IBs/AMCs/Brokerage firms inside our database to draw a bigger picture.

Grading Consensus

Price Target Consensus

-21.317% $12.53 · MISS

Nov. 6, 2024

Price Then

$57.81

Price Target

$71.31

Price Now

$58.78